0
Inquiry Basket

There is no product in the shopping cart, buy it!

Quantitative Human TLL1 (Glycosylated) Sandwich ELISA Kit (CAT#: GLJF-0525-HX64)

Datasheet
SizeQtyAdd To Basket
1×48 T
1×96 T

Product Description The quantitative human TLL1 (glycosylated) sandwich ELISA kit is designed to detect human tolloid like protein 1 (TLL1) levels. TLL1 is a zinc-dependent metalloprotease involved in processing procollagen C-propeptides and influencing developmental processes like dorsal-ventral patterning and skeletogenesis. The kit is suitable for various biological samples such as tissue homogenates, serum, plasma. Its sensitivity is 0.316 ng/mL, which can accurately detect low concentrations of TLL1 in the sample.
Target TLL1
N-Glycosylation Site 169, 359, 390, 626
Sample Types Tissue homogenates, serum, plasma
Sample Volume 100 μL
Sensitivity 0.316 ng/mL
Detection Principle Quantitative sandwich ELISA
Detection Range 2 ng/mL-30 ng/mL
Detection Time 1 h-5 h
Detection Wavelength 450 nm
Storage Store at 2-8°C for long term storage.
Species Human
Full Name Tolloid like protein 1
Alternate Names TLL1; Tolloid like protein 1; TLL1_HUMAN; Tolloid like 1
Uniprot No. O43897
Application The quantitative human TLL1 (glycosylated) sandwich ELISA kit is utilized to accurately measure the concentration of glycosylated TLL1 in biological samples. This application is crucial for research investigating TLL1's role in various physiological and pathological conditions, including developmental disorders and extracellular matrix remodeling.
Kit Components Pre-coated ELISA plate; Lyophilized standard; Biotin-labeled antibody; HRP-avidin; Various diluents; Wash buffer; TMB chromogenic substrate; Stop solution
Precision Intra-Assay: n=20, CV <8%;
Inter-Assay: n=20, CV <10%;
Recovery Serum sample: n=5, 85-100%;
Plasma sample: n=4, 80-100%;
Standard Curve
The standard curve is for reference only, and a new standard curve should be generated for each set of samples tested.
For Research Use Only.
Online Inquiry
Creative Biolabs-Glycoprotein Follow us on